Biomarkers in cancer epidemiology: An integrative approach

Carcinogenesis

Volumn 31, Issue 1, 2009, Pages 121-126

  Boffetta, Paolo ^a  

^a INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; COTININE; NICOTINIC RECEPTOR; NITROSAMINE; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN P16; PROTEIN P53; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR MARKER;

AIR POLLUTION; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CARCINOGENICITY; CHROMOSOME 15Q; DNA REPAIR; ENVIRONMENTAL EXPOSURE; FOOD CONTAMINATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LUNG CANCER; MOLECULAR EPIDEMIOLOGY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; REVIEW; SMOKING; WATER POLLUTION; DISEASE PREDISPOSITION; NEOPLASM;

DISEASE SUSCEPTIBILITY; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 74049124576     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp269     Document Type: Review

References (51)

1. Boffetta, P. et al. (2009) The causes of cancer in France. Ann. Oncol., 20, 550-555.
2. World Cancer Research Fund/American Institute for Cancer Research. (1997) Food, Nutrition, and the Prevention of Cancer: A Global Perspective. AICR, Washington, DC.
3. World Cancer Research Fund/American Institute for Cancer Research. (2007) Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. AICR, Washington, DC.
4. Willett, W.C. (2000) Nutritional epidemiology issues in chronic disease at the turn of the century. Epidemiol. Rev., 22, 82-86.
5. International Agency for Research on Cancer. (1972-2009) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 1-97. IARC, Lyon http://monographs.iarc.fr/ (7 October 2009, date last accessed).
6. International Agency for Research on Cancer. (2001) Radon-222 and its decay products. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 78. Some Internally Deposited Radionuclides. IARC, Lyon.
7. International Agency for Research on Cancer. (2004) Involuntary smoking. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 83, Tobacco Smoke and Involuntary Smoking. IARC, Lyon, pp. 1189-1413.
8. International Agency for Research on Cancer. Indoor emissions from household combustion of coal. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 95 Household Combustion of Solid Fuels and High-Temperature Frying. IARC, Lyon in press.
9. Institute of Medicine of the National Academies. (2006) Asbestos: Selected Cancers. The National Academies Press, Washington, DC.
10. International Agency for Research on Cancer. (2004) Arsenic in drinking-water. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 84. Some Drinking-water Disinfectants and Contaminants, including Arsenic. IARC, Lyon, pp. 39-267.
11. International Agency for Research on Cancer. (2002) Aflatoxins. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 82. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. IARC, Lyon, pp. 39-267.
12. Boffetta, P. (2002) Involuntary smoking and lung cancer. Scand. J. Work Environ. Health, 28, 30-40.
13. Taylor, R. et al. (2007) Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int. J. Epidemiol., 36, 1048-1059.
14. Brennan, P. et al. (2004) Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: a pooled analysis of two large studies. Int. J. Cancer, 109, 125-131.
15. Boffetta, P. et al. (1998) Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J. Natl Cancer Inst., 90, 1440-1450.
16. Nyberg, F. et al. (1998) European validation study of smoking and environmental tobacco smoke exposure in nonsmoking lung cancer cases and controls. Cancer Causes Control, 9, 173-182.
17. Fontham, E.T. et al. (1994) Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study. JAMA, 271, 1752-1759.
18. Pirie, K. et al. (2008) Passive smoking and breast cancer in never smokers: prospective study and meta-analysis. Int. J. Epidemiol., 37, 1069-1079.
19. Puntoni, R. et al. (1995) Mathematical modelling in risk/exposure assessment of tobacco related lung cancer. Carcinogenesis, 16, 1465-1471.
20. Seminara, D. et al. (2007) Human Genome Epidemiology Network; Network of Investigator Networks. The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology, 18, 1-8.
21. Gallicchio, L. et al. (2008) Carotenoids and the risk of developing lung cancer: a systematic review. Am. J. Clin. Nutr., 88, 372-383.
22. Boffetta, P. et al. (2006) Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 15, 1184-1188.
23. Yuan, J.M. et al. (2009) Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res., 69, 2990-2995.
24. Vineis, P. et al. (2000) Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat. Res., 463, 103-110.
25. Bain, C. et al. (2004) Lung cancer rates in men and women with comparable histories of smoking. J. Natl Cancer Inst., 96, 826-834.
26. Wu, W. et al. (2005) Determination of carcinogenic tobacco-specific nitrosamines in mainstream smoke from U.S.-brand and non-U.S.-brand cigarettes from 14 countries. Nicotine Tob. Res., 7, 443-451.
27. Chen, Z.M. et al. (1997) Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. JAMA, 278, 1500-1504.
28. Hainaut, P. et al. (2001) Patterns of p53 G->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis, 22, 367-377.
29. Vaissière, T. et al. (2009) Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res., 69, 243-252.
30. Brock, M.V. et al. (2008) DNA methylation markers and early recurrence in stage I lung cancer. N. Engl. J. Med., 358, 1118-1128.
31. Poynter, J.N. et al. (2009) Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol. Biomarkers Prev., in press.
32. Savage, S.A. et al. (2006) Genetic association studies in cancer: good, bad or no longer ugly? Hum. Genomics, 2, 415-421.
33. Thorgeirsson, T.E. et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature, 452, 638-642.
34. Hung, R.J. et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452, 633-637.
35. Amos, C.I. et al. (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet, 40, 616-622.
36. Wang, Y. et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet., 40, 1407-1409.
37. Rafnar, T. et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet., 41, 221-227.
38. McKay, J.D. et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat. Genet., 40, 1404-1406.
39. Shiraishi, K. et al. (2009) Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis, 30, 65-70.
40. Wu, C. et al. (2009) Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. Cancer Res., 69, 5065-5072.
41. Schwartz, A.G. et al. (2009) Racial differences in the association between SNPs on 15q25.1, smoking behavior, and risk of non-small cell lung cancer. J. Thorac. Oncol., in press.
42. Young, R.P. et al. (2008) Lung cancer gene associated with COPD: triple whammy or possible confounding effect? Eur. Respir. J., 32, 1158-1164.
43. Le Marchand, L. et al. (2008) Smokers with the CHRNA lung cancerassociated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res., 68, 9137-9140.
44. Blasco, M.A. (2005) Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet., 6, 611-622.
45. Lin, X. et al. (2006) Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin. Cancer Res., 12, 5720-5725.
46. Shete, S. et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet., 41, 899-904.
47. Li, C. et al. (2009) DNA repair phenotype and cancer susceptibility-a mini review. Int. J. Cancer, 124, 999-1007.
48. Wei, Q. et al. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J. Natl Cancer Inst., 92, 1764-1772.
49. Gorlova, O.Y. et al. (2008) DNA repair capacity and lung cancer risk in never smokers. Cancer Epidemiol. Biomarkers Prev., 17, 1322-1328.
50. Bosken, C.H. et al. (2002) An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. J. Natl Cancer Inst., 94, 1091-1099.
51. Spitz, M.R. et al. (2008) An expanded risk prediction model for lung cancer. Cancer Prev. Res., 1, 250-254.